Glaucoma News

Treating ocular surface disease in patients with glaucoma may improve IOP control and reduce the need for filtering surgery, according to a study.

NEW ORLEANS – Heidelberg Engineering advances its technology to provide clinicians with better tools to manage their patients, Steve Thomas said here at the OIS meeting during SECO.

The use of a single trabecular microbypass stent provided a sustained reduction in IOP in patients that presented with mild to severe open-angle glaucoma, an effect that became more robust as baseline IOP increased, according to a study published in the Journal of Cataract & Refractive Surgery.

Optometrists in Massachusetts are attempting once again to obtain the right to treat glaucoma with the filing of SD74, “An act ensuring consumer choice and equal access to eye care.”

NEW ORLEANS – The medical model of eye care is doctor-patient centric and entails dilated eye exams, problem-focused care, therapeutics, treatment strategies, contact lens fitting and doctor-driven dispensing of optical lenses and frames, Maria Sampalis, OD, said here at SECO.

ATHENS, Greece — Autologous platelet-rich plasma showed efficacy in treating extreme ocular hypotension in a series of patients presented here at the European Society of Cataract and Refractive Surgeons Winter Meeting.

Eyenovia will include a broad patient population, including patients with chronic angle closure glaucoma, open-angle glaucoma and ocular hypertension, in a phase 3 trial of MicroProst, according to a press release.

SAN FRANCISCO — Thomas W. Samuelson, MD, discusses his participation in panels regarding FDA approvals and new, innovative glaucoma technologies at the Glaucoma 360: New Horizons Forum.

ORLANDO — At Cataract Surgery: Telling It Like It Is, I. Paul Singh, MD, discusses how new glaucoma therapies, due to a different mechanism of action from previous treatments, may be able to change the pathology of the disease and may have the ability to enhance current treatments earlier in the course of the disease.

SAN FRANCISCO — At Glaucoma 360: New Horizons Forum, Felipe A. Medeiros, MD, PhD, discusses the potential role of virtual reality in the future of glaucoma detection and treatment.